Cargando…

The Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations, Outcomes (REACH-OUT) study: real-world clinical practice in schizophrenia

BACKGROUND: Outpatient facilities, such as community behavioral health organizations (CBHOs), play a critical role in the care of patients with serious mental illness, but there is a paucity of “real-world” patient outcomes data from this health care setting. Therefore, we conducted The Research and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joshi, Kruti, Mao, Lian, Biondi, David M., Millet, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789676/ https://www.ncbi.nlm.nih.gov/pubmed/29378547 http://dx.doi.org/10.1186/s12888-018-1594-1

Ejemplares similares

Comparison and predictors of treatment adherence and remission among patients with schizophrenia treated with paliperidone palmitate or atypical oral antipsychotics in community behavioral health organizations
por: Anderson, Jeffrey P., et al.
Publicado: (2017)

Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics
por: Correll, Christoph U., et al.
Publicado: (2022)

Economic burden in Medicaid beneficiaries with recently relapsed schizophrenia or with uncontrolled symptoms of schizophrenia not adherent to antipsychotics
por: Pilon, Dominic, et al.
Publicado: (2021)

Real‐world effectiveness of antipsychotics
por: Tiihonen, J.
Publicado: (2016)

Associations Between Relapses and Psychosocial Outcomes in Patients With Schizophrenia in Real-World Settings in the United States
por: Lin, Dee, et al.
Publicado: (2021)

Nepal: trying to reach out to the community
por: Shyangwa, Pramod M., et al.
Publicado: (2008)

Quantitative efficacy of three antipsychotic drugs for schizophrenia based on a real-world study in China
por: Zhang, Lei, et al.
Publicado: (2019)

A Real-World Observation of Antipsychotic Effects on Brain Volumes and Intrinsic Brain Activity in Schizophrenia
por: Chen, Yifan, et al.
Publicado: (2022)

T223. REAL WORLD EFFECTIVENESS OF ANTIPSYCHOTIC DRUGS IN PATIENTS WITH SCHIZOPHRENIA: A 10-YEARS RETROSPECTIVE STUDY
por: Lee, Tae Young, et al.
Publicado: (2018)

HSD26 Impact of the COVID-19 Pandemic on Real-World Antipsychotic Treatment Patterns in Patients with Schizophrenia
por: Liu, Z, et al.
Publicado: (2022)

Treatment patterns in Medicaid patients with schizophrenia initiated on a first- or second-generation long-acting injectable versus oral antipsychotic
por: Pilon, Dominic, et al.
Publicado: (2017)

Reaching out
por: Mack, Katherine, et al.
Publicado: (2020)

Economic Impact in Medicaid Beneficiaries with Schizophrenia and Cardiometabolic Comorbidities Treated with Once-Monthly Paliperidone Palmitate vs. Oral Atypical Antipsychotics
por: Lafeuille, Marie-Hélène, et al.
Publicado: (2018)

Adherence, healthcare resource utilization and Medicaid spending associated with once-monthly paliperidone palmitate versus oral atypical antipsychotic treatment among adults recently diagnosed with schizophrenia
por: Pilon, Dominic, et al.
Publicado: (2017)

Second-Generation Antipsychotics’ Effectiveness and Tolerability: A Review of Real-World Studies in Patients with Schizophrenia and Related Disorders
por: Fabrazzo, Michele, et al.
Publicado: (2022)

Spines reach out
por: LeBrasseur, Nicole
Publicado: (2005)

Reaching Out in Business
Publicado: (1916)

Impact of Lurasidone and Other Antipsychotics on Body Weight: Real-World, Retrospective, Comparative Study of 15,323 Adults with Schizophrenia
por: Pochiero, Ilena, et al.
Publicado: (2021)

A meta-analysis of effectiveness of real-world studies of antipsychotics in schizophrenia: Are the results consistent with the findings of randomized controlled trials?
por: Katona, Lajos, et al.
Publicado: (2021)

Systematic Review of Real-World Treatment Patterns of Oral Antipsychotics and Associated Economic Burden in Patients with Schizophrenia in the United States
por: Martin, Amber, et al.
Publicado: (2022)

Persistence of Antipsychotic Use After Clozapine Discontinuation: A Real‐World Study Across Antipsychotics
por: Stam, Noraly, et al.
Publicado: (2020)

Dental Outreach Program – How Effective it is in Reaching Out to the Community
por: Dagli, Rushabh, et al.
Publicado: (2015)

Readmission Rates of Patients with Schizophrenia Treated with Depot Antipsychotics versus Oral Antipsychotics in a Community Hospital
por: Espiridion, Eduardo D, et al.
Publicado: (2018)

Long-acting Injectable Antipsychotics during the COVID-19 pandemic in schizophrenia: An observational study in a real-world clinical setting
por: Barlati, Stefano, et al.
Publicado: (2022)

New Brochures Reach Out!
Publicado: (1998)

Landscape ecology reaching out
por: Kienast, Felix, et al.
Publicado: (2021)

Recruitment and reach in a pragmatic behavioral weight loss randomized controlled trial: implications for real-world primary care practice
por: Befort, Christie A., et al.
Publicado: (2020)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005)

Weight gain and comorbidities associated with oral second-generation antipsychotics: analysis of real-world data for patients with schizophrenia or bipolar I disorder
por: Doane, Michael J., et al.
Publicado: (2022)

Patient-psychiatrist discordance and drivers of prescribing long-acting injectable antipsychotics for schizophrenia management in the real-world: a point-in-time survey
por: Keenan, Alexander, et al.
Publicado: (2022)

Successful high dose antipsychotic treatment with cariprazine in patients on the schizophrenia spectrum: Real-world evidence from a Spanish hospital setting
por: Galmes, Lluis Niell, et al.
Publicado: (2023)

Supplement study update for Reach Out: a multi-arm randomized trial of behavioral interventions for hypertension initiated in the emergency department: Reach Out Cognition
por: Skolarus, Lesli E., et al.
Publicado: (2021)

A Cross-Sectional Study of Patient Out-of-Pocket Costs for Antipsychotics Among Medicaid Beneficiaries with Schizophrenia
por: Lin, Dee, et al.
Publicado: (2023)

Rare sex or out of reach equilibrium? The dynamics of F(IS) in partially clonal organisms
por: Reichel, Katja, et al.
Publicado: (2016)

Treatment Patterns and Antipsychotic Medication Adherence Among Commercially Insured Patients With Schizoaffective Disorder in the United States
por: Joshi, Kruti, et al.
Publicado: (2016)

Long-Term Antipsychotic Effectiveness and Comparison of the Efficacy of Monotherapy and Polypharmacy in Schizophrenia: A 3-Years Follow-Up “Real World” Study in China
por: Zhang, Lei, et al.
Publicado: (2022)

The Use of Second-Generation Antipsychotics in Patients with Severe Schizophrenia in the Real World: The Role of the Route of Administration and Dosage—A 5-Year Follow-Up
por: Fernández-Miranda, Juan J., et al.
Publicado: (2022)

Pharmacogenetic testing in schizophrenia in real clinical practice: before or after antipsychotic -induced adverse drug reactions development?
por: Abdyrakhmanova, A., et al.
Publicado: (2022)

Reaching out from the European school
por: Ellis, Nick, et al.
Publicado: (2017)

Reach out and gRab something
por: Robinson, Richard
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_u2mkbjbo2fsi7j7tp2j285mi1n